Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Instil Bio Inc.
TILCurrent price
12.78 USD
-6.83 USD (-34.83%)
Last closed
20.52 USD
Company
instilbio.com
ISIN
US45783C2008
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
128 620 624 USD
Yield for 12 month
+22.00 %
1Y
3Y
5Y
10Y
15Y
TIL
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial for the treatment of patients with chemotherapy in patients with advanced/metastatic non-small cell lung cancer. The company also conducts a Phase 1 open label trial in China for AXN-2510/IMM2510 as monotherapy in patients with advanced solid tumors, including triple-negative breast cancer, squamous non-small cell lung cancer, hepatocellular carcinoma, renal cell carcinoma, and rare solid tumors, such as soft tissue sarcomas and thymic cancer. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas. Address: 3963 Maple Avenue, Dallas, TX, United States, 75219
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
113.67 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-4 756 000 USD
Current Quarter
–
Last Quarter
–
Key Figures TIL
1 year
3 years
5 years
10 years
EBITDA
-56 348 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-12.72 %
PEG Ratio
–
Return On Equity TTM
-37.51 %
Wall Street Target Price
113.67 USD
Revenue TTM
–
Book Value
25.96 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
138 000 USD
Earnings per share
-11.39 USD
Diluted Eps TTM
-11.39 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics TIL
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History TIL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:20
Payout Ratio TTM
–
Last Split Date
08.12.2023
Stock Valuation TIL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
43 213.95
Price Sales TTM
55 329.79
Enterprise Value EBITDA
0.62
Price Book MRQ
0.76
Financials TIL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TIL
For 52 weeks
9.62 USD
92.00 USD
50 Day MA
18.61 USD
Shares Short Prior Month
547 298
200 Day MA
24.64 USD
Short Ratio
6.71
Shares Short
565 118
Short Percent
14.99 %
BeatStart